Safety and Antiretroviral Effects of Combined Didanosine and Stavudine Therapy in HIV-Infected Individuals With CD4 Counts of 200 to 500 cells/mm3-Reference-Cited by-同舟云学术

Safety and Antiretroviral Effects of Combined Didanosine and Stavudine Therapy in HIV-Infected Individuals With CD4 Counts of 200 to 500 cells/mm3

Published:1999-09 Issue:1 Volume:22 Page:39
ISSN:1077-9450
Container-title:Journal of Acquired Immune Deficiency Syndromes
language:en
Short-container-title:Journal of Acquired Immune Deficiency Syndromes

Author:

Pollard Richard B.,Peterson Dolores,Hardy David,Pottage John,Murphy Robert L.,Gathe Joseph,Beall Gildon,Rutkievicz Victoria,Reynolds Laurie,Cross Anne P.,Dunkle Lisa M.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Virology,Immunology,Immunology and Allergy

Reference20 articles.

1. Treatment with Lamivudine, Zidovudine, or Both in HIV-Positive Patients with 200 to 500 CD4+ Cells per Cubic Millimeter

2. The Relation of Virologic and Immunologic Markers to Clinical Outcomes after Nucleoside Therapy in HIV-Infected Adults with 200 to 500 CD4 Cells per Cubic Millimeter

3. Randomised trial of addition of lamivudine or lamivudine plus loviride to zidovudine-containing regimens for patients with HIV-1 infection: the CAESAR trial

4. A Trial Comparing Nucleoside Monotherapy with Combination Therapy in HIV-Infected Adults with CD4 Cell Counts from 200 to 500 per Cubic Millimeter

5. Evaluation of reverse transcriptase and protease inhibitors in two-drug combinations against human immunodeficiency virus replication

Cited by 29 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Low dose versus high dose stavudine for treating people with HIV infection;Cochrane Database of Systematic Reviews;2015-01-28

2. Neurologic Diseases Caused by Human Immunodeficiency Virus Type 1 and Opportunistic Infections;Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases;2015

3. Estimation of Intracellular Concentration of Stavudine Triphosphate in HIV-Infected Children Given a Reduced Dose of 0.5 Milligrams per Kilogram Twice Daily;Antimicrobial Agents and Chemotherapy;2013-12-02

4. Neurologic Diseases Caused by Human Immunodeficiency Virus Type 1 and Opportunistic Infections;Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases;2010

5. Toxicities Associated with Dual Nucleoside Reverse‐Transcriptase Inhibitor Regimens in HIV‐Infected Children;The Journal of Infectious Diseases;2008-12